3 out of 4 commercially insured patients on mealtime insulin have coverage for the Dexcom G6 Continuous Glucose Monitoring (CGM) System
Zero fingersticks or scanning required.
Dexcom CGM use is clinically proven to lower A1C, reduce hyper- and hypoglycemia, and increase time in range.
Includes a predictive Urgent Low Soon alert and a suite of customizable high and low glucose alerts.
92% of surveyed US patients said that Dexcom G6 is easy to use
Contact your pharmacy wholesale partner to order or visit provider.dexcom.com.